Prevalence of Sydenham’s chorea in patients with Acute Rheumatic fever in Nepal

Authors

  • PR Regmi Cardiology Unit, Bir Hospital, NAMS
  • A Shrestha Neurology Unit, Bir Hospital, NAMS
  • HH Khanal Cardiology Unit, Bir Hospital, NAMS
  • BP Nepal Cardiology Unit, Bir Hospital, NAMS
  • P Chapagain Cardiology Unit, Bir Hospital, NAMS

DOI:

https://doi.org/10.3126/njh.v9i1.8345

Keywords:

Acute Rheumatic Fever, RF/RHD prevention and control programme, Sydenham’s chorea

Abstract

Background Sydenham’s Chorea (SC) is a major manifestation of acute rheumatic fever (ARF) and is the only evidence of ARF in approximately 20% of cases. There are no published reports on prevalence of SC in patients with ARF in Nepal.

Objectives This retrospective study was done to find out the prevalence of SC in patients with ARF in Nepal.

Methods Four years data of 672 patients with ARF from the RF/RHD registry of National RF/RHD prevention & control programme launched by Ministry of Health and Population & Nepal Heart Foundation in 32 hospitals throughout Nepal were analyzed.

Results Prevalence of SC as a major manifestation of ARF in Nepalese patients was found to be 3.87%. Females were mostly affected with a female-to-male ratio of 3:1. Patients of age group 10-15 years were affected the most. SC was the third most common manifestation of ARF after Arthritis and Carditis.

DOI: http://dx.doi.org/10.3126/njh.v9i1.8345

Nepalese Heart Journal Vol.9(1) 2012 pp.30-32

Downloads

Download data is not yet available.
Abstract
693
PDF
1360

Downloads

Published

2013-07-21

How to Cite

Regmi, P., Shrestha, A., Khanal, H., Nepal, B., & Chapagain, P. (2013). Prevalence of Sydenham’s chorea in patients with Acute Rheumatic fever in Nepal. Nepalese Heart Journal, 9(1), 30–32. https://doi.org/10.3126/njh.v9i1.8345

Issue

Vol. 9 No. 1 (2012)

Section

Original Articles

License

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use.